--- title: Multiple agreements with University College London description: Saphetor, SA, a Swiss precision medicine company dedicated to advancing personalized diagnostics based on next-generation DNA sequencing, announced today a research partnership with the Exome Consortium of University College London (UCL), led by Dr. Vincent Plagnol. --- [![VarSome](https://news.varsome.com/hubfs/VarSome_February2020%20Theme/Images/logo.png)](https://varsome.com/) - Editions - [More about VarSome.com](https://varsome.com/varsome-editions/varsome/) - [More about VarSome Premium](https://varsome.com/varsome-editions/varsome-premium/) - [More about VarSome Clinical](https://varsome.com/varsome-editions/varsome-clinical/) - [Learn more about APIs](https://varsome.com/information/varsome-api-info/) - About - Resources - [Library](https://varsome.com/library/) - [Documentation](https://docs.varsome.com/) - [Query types](https://varsome.com/about/examples/) - [IVDR](https://landing.varsome.com/ivdr-whitepaper) - [Germline Classification](https://varsome.com/about/resources/acmg-implementation/) - [Somatic Classification](https://varsome.com/about/resources/amp-implementation/) - Partners - [Distributors](https://varsome.com/distributors/) - [Partners](https://varsome.com/partners/) - [Become a partner](https://landing.varsome.com/become-varsome-partner) - General - [The Company](https://saphetor.com/about/) - [Cite VarSome](https://varsome.com/about/varsome-citations/) - [Link to VarSome](https://varsome.com/how-do-i-create-link-varsome/) - [Contact](https://landing.varsome.com/contact) - [Community](https://varsome.com/community-contributions/) - [Blog](https://blog.varsome.com/) [Press Releases](https://news.varsome.com/en/tag/press-releases) [Partnerships](https://news.varsome.com/en/tag/partnerships) # Multiple agreements with University College London By [Andreas Massouras](https://news.varsome.com/en/author/andreas-massouras) on June, 1 2017 ### Categories - Select a Topic - [All](https://news.varsome.com/en) - [Partnerships](https://news.varsome.com/en/tag/partnerships) - [News](https://news.varsome.com/en/tag/news) - [Press Releases](https://news.varsome.com/en/tag/press-releases) - [VarSome Clinical](https://news.varsome.com/en/tag/varsome-clinical) - [Community](https://news.varsome.com/en/tag/community) - [Platform Updates](https://news.varsome.com/en/tag/platform-updates) - [VarSome.com](https://news.varsome.com/en/tag/varsome-com) - [Events](https://news.varsome.com/en/tag/events) - [Oncology](https://news.varsome.com/en/tag/oncology) - [Technology](https://news.varsome.com/en/tag/technology) - [VarSome.com Premium](https://news.varsome.com/en/tag/varsome-com-premium) - [Conferences](https://news.varsome.com/en/tag/conferences) - [Germline](https://news.varsome.com/en/tag/germline) - [VarSome in Action](https://news.varsome.com/en/tag/varsome-in-action) - [VarSome Team](https://news.varsome.com/en/tag/varsome-team) - [Awareness Days](https://news.varsome.com/en/tag/awareness-days) - [Whitepaper](https://news.varsome.com/en/tag/whitepaper) - [ACMG](https://news.varsome.com/en/tag/acmg) - [KnowledgeHub](https://news.varsome.com/en/tag/knowledgehub) - [Research Brief](https://news.varsome.com/en/tag/research-brief) - [VarSome API](https://news.varsome.com/en/tag/varsome-api) - [Application Note](https://news.varsome.com/en/tag/application-note) - [Community Q&A](https://news.varsome.com/en/tag/community-qa) - [VarSome Insights](https://news.varsome.com/en/tag/varsome-insights) ### Stay up to date ##### Search The Blog [Back to main Blog](https://news.varsome.com/en) [![](https://news.varsome.com/hs-fs/hubfs/andreas.jpg?height=100&name=andreas.jpg)](https://news.varsome.com/en/author/andreas-massouras#blog-listing-section) ###### [Andreas Massouras](https://news.varsome.com/en/author/andreas-massouras#blog-listing-section) CEO & Founder LAUSANNE, Switzerland – May 25th 2017 – Saphetor, SA, a Swiss precision medicine company dedicated to advancing personalized diagnostics based on next-generation DNA sequencing, announced today a research partnership with the Exome Consortium of University College London (UCL), led by Dr. Vincent Plagnol. As part of a series of service agreements with UCL-affiliated research groups, Prof. Michel Michaelides and his team will use Saphetor’s precision medicine platform to investigate eye disorders in patients. By partnering with world-class researchers and clinicians at UCL, Saphetor seeks to improve genetic diagnoses that will enhance prognosis counseling for patients and identify those who may be eligible for specific clinical trials. Dr. Vincent Plagnol is a Reader in statistical genetics at the UCL Genetics Institute with a focus on translational research. His work on rare disease genetics is widely published, both in pioneering methodological advances and significant molecular discoveries. Dr. Plagnol said, “We are looking forward to working with Saphetor, as their fast turnaround and comprehensive platform will ensure timely and accurate results in our wide range of research projects.” Prof. Michel Michaelides is a highly-cited Professor of Ophthalmology at University College London, based at the Institute of Ophthalmology, a premier vision research center. He is also a Consultant Ophthalmologist at Moorfields Eye Hospital, one of the most respected eye hospitals in the world. Prof. Michaelides said, “We are pleased to work with Saphetor, as their advanced analytical capabilities are already driving new findings in congenital eye conditions.” Andreas Massouras, CEO of Saphetor, said: “We are very honored to work with Dr. Plagnol, Prof. Michaelides, and their collaborators in the UCL Exome Consortium. We intend to accelerate novel research findings on a number of exciting projects.” **About Saphetor** Saphetor, SA, founded in 2014, is a Swiss precision medicine company dedicated to identifying human genetic variants with improved accuracy by leveraging proprietary algorithms and expert domain knowledge. Capitalizing on the emergence of exome sequencing and whole-genome sequencing, Saphetor’s suite of services offers clinicians intuitive, data-driven solutions to make faster, more accurate diagnoses and treatment decisions. Saphetor is the creator of [VarSome.com](https://varsome.com/), a free and widely used genomic variant search engine with more than 33 billion data points. [Previous Post](https://news.varsome.com/en/saphetor-signs-agreement-with-geneva-university-hospitals-to-deploy-its-platform-for-advanced-ngs-analysis) [Next Post](https://news.varsome.com/en/saphetor-precision-medicine-platform-wow-serving-aurigen-patients-to-enhance-discovery-of-personalized-cancer-therapies) ### Stay up to date ## Latest News [See all blog posts](https://blog.varsome.com) ![](https://news.varsome.com/hubfs/VarSome_February2020%20Theme/Images/logo.png) - VarSome Suite - [VarSome.com](https://saphetor.com/varsome-editions/varsome/) - [VarSome Premium](https://saphetor.com/varsome-editions/varsome-premium/) - [VarSome Clinical](https://saphetor.com/varsome-editions/varsome-clinical/) - [VarSome API](https://varsome.com/information/varsome-api-info/) - System Status - [System Status](http://status.saphetor.com/) - Resources - [Query Examples](https://varsome.com/about/examples/) - [Documentation](https://docs.varsome.com/) - [Help Center](https://docs.varsome.com/en) - [Cite VarSome](https://news.varsome.com/en/cite-varsome-the-human-genomic-variant-search-engine) - The Company - [About Saphetor SA](https://saphetor.com/about/) - [News](https://blog.varsome.com) - [Distributors](https://landing.varsome.com/distributors) - [Contact](https://saphetor.com/contact/) - Legal - [Terms of Use](https://varsome.com/terms/) - [Privacy Policy](https://varsome.com/privacy/) VarSome Suite is brought to you by [Saphetor SA](https://saphetor.com). © 2024 Saphetor SA – All Rights Reserved.